WHO says antibacterial pipeline lacks innovation

WHO says antibacterial pipeline lacks innovation

Despite ongoing concern over antibiotic resistance, a new report finds there are fewer antibacterial medicines in clinical pipelines than just two years ago and relatively few qualify as innovative, suggesting the majority of treatments would be insufficient to tackle the fast-growing public health threat. Specifically, the number of antibacterial medicines under development fell to 90…

Read More